HB2176 exempts collaborative drug therapy agreements from public disclosure under Washington's public records act.

HB2176 amends Washington's public records act to exempt collaborative drug therapy agreements from disclosure. These agreements, determined by the pharmacy quality assurance commission, are confidential and cannot be disclosed except under specific circumstances. If disclosed, personally identifiable information in the agreement, excluding that of disciplined license holders, remains confidential.

HB2176 exempts collaborative drug therapy agreements from public disclosure under Washington's public records act.

HB2176 amends Washington's public records act to exempt collaborative drug therapy agreements from disclosure. These agreements, determined by the pharmacy quality assurance commission, are confidential and cannot be disclosed except under specific circumstances. If disclosed, personally identifiable information in the agreement, excluding that of disciplined license holders, remains confidential.